We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-15.72%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$4.46B
AUM Growth
-$6B
Cap. Flow
-$4.51B
Cap. Flow %
-101.07%
Top 10 Hldgs %
21.21%
Holding
7,134
New
733
Increased
2,939
Reduced
2,324
Closed
739

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$411M
2
MSFT icon
Microsoft
MSFT
+$372M
3
AMZN icon
Amazon
AMZN
+$192M
4
TSLA icon
Tesla
TSLA
+$121M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$111M

Sector Composition

Rank Sector Weight
1 Technology 22.55%
2 Healthcare 10.82%
3 Consumer Discretionary 9.19%
4 Financials 8.34%
5 Communication Services 7.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AUMN
4976
DELISTED
Golden Minerals Company
AUMN
$6K ﹤0.01%
608
+471
+344% +$4.88K
THCPU
4977
DELISTED
Thunder Bridge Capital Partners IV, Inc. Unit
THCPU
$6K ﹤0.01%
600
+244
+69% +$2.42K
JWSM
4978
DELISTED
Jaws Mustang Acquisition Corp.
JWSM
$6K ﹤0.01%
612
+497
+432% +$4.88K
PIXY
4979
DELISTED
ShiftPixy, Inc. Common Stock
PIXY
$6K ﹤0.01%
+1
New +$13.8K
SEEL
4980
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$6K ﹤0.01%
2
-2
-50% -$5.21K
ALIM
4981
DELISTED
Alimera Sciences
ALIM
$6K ﹤0.01%
+1,156
New +$6.36K
LKCO
4982
DELISTED
Luokung Technology Corp Ordinary Shares
LKCO
$6K ﹤0.01%
+60
New +$6.63K
MMAT
4983
DELISTED
Meta Materials Inc. Common Stock
MMAT
$6K ﹤0.01%
62
+4
+7% +$597
IMAQU
4984
DELISTED
International Media Acquisition Corp. Unit
IMAQU
$6K ﹤0.01%
577
-101
-15% -$1.02K
BTCY
4985
DELISTED
Biotricity, Inc. Common Stock
BTCY
$6K ﹤0.01%
592
+374
+172% +$3.26K
RWODU
4986
DELISTED
Redwoods Acquisition Corp. Unit
RWODU
$6K ﹤0.01%
+552
New +$5.56K
BIOL
4987
DELISTED
Biolase, Inc.
BIOL
$6K ﹤0.01%
13
+4
+44% +$2.2K
AVGR
4988
DELISTED
Avinger, Inc. Common Stock
AVGR
$6K ﹤0.01%
276
+271
+5,420% +$8.98K
CTHR
4989
DELISTED
Charles & Colvard Ltd
CTHR
$6K ﹤0.01%
477
+109
+30% +$1.53K
ALTU
4990
DELISTED
Altitude Acquisition Corp
ALTU
$6K ﹤0.01%
574
-2,056
-78% -$20.5K
GMBL
4991
DELISTED
Esports Entertainment Group Inc. Common Stock
GMBL
0
NSTB
4992
DELISTED
Northern Star Investment Corp. II
NSTB
$6K ﹤0.01%
574
-500
-47% -$4.9K
RAIN
4993
DELISTED
Rain Oncology Inc. Common Stock
RAIN
$6K ﹤0.01%
1,047
-982
-48% -$3.37K
ADEX.U
4994
DELISTED
Adit EdTech Acquisition Corp Units
ADEX.U
$6K ﹤0.01%
613
VAPO
4995
DELISTED
Vapotherm, Inc. Common Stock
VAPO
$6K ﹤0.01%
303
-633
-68% -$23.2K
BRD.U
4996
DELISTED
Beard Energy Transition Acquisition Corp. Units, each consisting of one share of Class A Common Stock and one-half of one Warrant
BRD.U
$6K ﹤0.01%
600
+500
+500% +$5.02K
VCXAU
4997
DELISTED
10X Capital Venture Acquisition Corp II Unit
VCXAU
$6K ﹤0.01%
613
-9
-1% -$90
PYR
4998
DELISTED
PyroGenesis Canada Inc. Common Shares
PYR
$6K ﹤0.01%
2,894
-12,782
-82% -$27.2K
AAC
4999
DELISTED
Ares Acquisition Corporation
AAC
$6K ﹤0.01%
599
-501
-46% -$4.92K
CCV
5000
DELISTED
Churchill Capital Corp V
CCV
$6K ﹤0.01%
597
-1,640
-73% -$16.1K

Similar funds

Tower Research Capital (TRC)'s Q2 2022 Portfolio in Review

As of Q2 2022, Tower Research Capital (TRC) held 7,134 positions worth $4.46B, down 57% from $10.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.51B in Q2 2022, closing 739 positions and reducing 2,324 holdings. Its most notable exit was iShares MSCI USA Value Factor ETF, an estimated $13.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Russell 1000 Value ETF worth $23.4M.

  • Tower Research Capital (TRC)'s largest Q2 2022 buy was iShares Russell 1000 Value ETF: 161,690 shares worth $23.4M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q2 2022, an estimated $41.1M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2022 reduction was Apple, cutting an estimated $411M.
  • Tower Research Capital (TRC) fully exited iShares MSCI USA Value Factor ETF in Q2 2022, selling an estimated $13.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 21% of its $4.46B portfolio in Q2 2022.
  • Tower Research Capital (TRC) opened 733 new positions and closed 739 in Q2 2022.
  • Tower Research Capital (TRC)'s portfolio value fell 57% quarter-over-quarter to $4.46B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2022, filed 15 Aug 2022.